545 related articles for article (PubMed ID: 24176465)
1. Statin myotoxicity: a review of genetic susceptibility factors.
Needham M; Mastaglia FL
Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to statin myopathy.
Vladutiu GD
Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Mohassel P; Mammen AL
Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
[TBL] [Abstract][Full Text] [Related]
4. Statin-induced myopathy: the two faces of Janus.
Arora R; Liebo M; Maldonado F
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287
[TBL] [Abstract][Full Text] [Related]
5. The genetics of statin-induced myopathy.
Ghatak A; Faheem O; Thompson PD
Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of statin intolerance.
Oh J; Ban MR; Miskie BA; Pollex RL; Hegele RA
Lipids Health Dis; 2007 Mar; 6():7. PubMed ID: 17376224
[TBL] [Abstract][Full Text] [Related]
7. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
Harper CR; Jacobson TA
Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
[TBL] [Abstract][Full Text] [Related]
8. The role of mitochondria in statin-induced myopathy.
Apostolopoulou M; Corsini A; Roden M
Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
[TBL] [Abstract][Full Text] [Related]
9. Statin induced myotoxicity.
Sathasivam S
Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
[TBL] [Abstract][Full Text] [Related]
10. Approach to clinical and genetic characterization of statin-induced myopathy.
Feng Q
Methods Mol Biol; 2014; 1175():67-90. PubMed ID: 25150867
[TBL] [Abstract][Full Text] [Related]
11. Statins and myotoxicity: a therapeutic limitation.
Tiwari A; Bansal V; Chugh A; Mookhtiar K
Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
[TBL] [Abstract][Full Text] [Related]
12. Does simvastatin cause more myotoxicity compared with other statins?
Backes JM; Howard PA; Ruisinger JF; Moriarty PM
Ann Pharmacother; 2009 Dec; 43(12):2012-20. PubMed ID: 19920157
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics and adverse drug reactions: the case of statins.
Giorgi MA; Caroli C; Arazi HC; Di Girolamo G
Expert Opin Pharmacother; 2011 Jul; 12(10):1499-509. PubMed ID: 21568825
[TBL] [Abstract][Full Text] [Related]
14. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M
Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced myopathy: a review and update.
Abd TT; Jacobson TA
Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 and statin-related myopathy.
Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
[TBL] [Abstract][Full Text] [Related]
17. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
18. Agents and mechanisms of toxic myopathy.
Kuncl RW
Curr Opin Neurol; 2009 Oct; 22(5):506-15. PubMed ID: 19680127
[TBL] [Abstract][Full Text] [Related]
19. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
20. Narrative review: statin-related myopathy.
Joy TR; Hegele RA
Ann Intern Med; 2009 Jun; 150(12):858-68. PubMed ID: 19528564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
